Trials
Search / Trial NCT06425627

Spinal Versus General Anesthesia on Postoperative Pulmonary Complications

Launched by TONGJI HOSPITAL · May 17, 2024

Trial Information

Current as of February 18, 2025

Recruiting

Keywords

Hip Fracture Delayed Surgery Pulmonary Complication Spinal Anesthesia General Anesthesia

ClinConnect Summary

This clinical trial is studying the effects of two types of anesthesia—spinal anesthesia and general anesthesia—on patients who are having surgery for hip fractures. The main goal is to see if one type of anesthesia leads to fewer breathing problems after surgery compared to the other. The trial is currently looking for participants who are at least 65 years old, in relatively good health (classified as ASA Class I to III), and who need surgery for specific types of hip fractures that are not done urgently.

To join the study, participants should be able to walk a short distance without help before their fracture, and they should not have certain serious health conditions like heart failure or asthma. If you or someone you know meets these criteria and is interested in participating, they can expect to be part of a study that may help improve care for future patients undergoing hip surgery. The trial has a recruiting status, meaning they are actively looking for volunteers.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients ≥ 65 years old
  • ASA Class I \~ III
  • Surgical repair of femoral neck, intertrochanteric or subtrochanteric fractures
  • The time from diagnosis to surgery is more than 48 hours
  • Exclusion Criteria:
  • Unable to walk about 3 meters or across a room without assistance before the fracture
  • Emergency surgery
  • Congestive heart failure, asthma, anemia (Hb \< 90 g/L), hypoalbuminemia (ALB \< 35g/L)
  • Abnormal coagulation function
  • Severe aortic stenosis
  • Injection site infection or increased intracranial pressure
  • Patients have participated in previous trials or have been determined by a surgeon or anesthesiologist to be unsuitable for randomization
  • The written informed consent of the patient or his/her representative cannot be obtained

Trial Officials

Tianzhu Liu, M.D.

Principal Investigator

Tongji Hospital

About Tongji Hospital

Tongji Hospital, affiliated with Tongji Medical College of Huazhong University of Science and Technology, is a leading medical institution in China dedicated to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary team of experts, Tongji Hospital focuses on translating scientific discoveries into effective treatments and therapies. The hospital is committed to enhancing patient care by conducting rigorous clinical trials that adhere to the highest ethical and regulatory standards, fostering collaboration with both national and international research communities to drive medical advancements.

Locations

Wuhan, Hubei, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0